Lymphomyosot Slovensko - slovenčina - ŠÚKL (Štátny ústav pre kontrolu liečiv)

lymphomyosot

biologische heilmittel heel gmbh, nemecko - iné liečivá - 93 - homeopatica

Lymphomyosot Slovensko - slovenčina - ŠÚKL (Štátny ústav pre kontrolu liečiv)

lymphomyosot

biologische heilmittel heel gmbh, nemecko - iné liečivá - 93 - homeopatica

Dimethyl fumarate Mylan Európska únia - slovenčina - EMA (European Medicines Agency)

dimethyl fumarate mylan

mylan ireland limited - dimetylfumarát - roztrúsená skleróza, recidivujúce-odosielajúcej - imunosupresíva - dimethyl fumarate mylan is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.

Dimethyl fumarate Polpharma Európska únia - slovenčina - EMA (European Medicines Agency)

dimethyl fumarate polpharma

zaklady farmafarmaceutyczne polpharma s.aceutyczne polpharma s.a. - dimetylfumarát - roztrúsená skleróza, recidivujúce-odosielajúcej - imunosupresíva - dimethyl fumarate polpharma is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.

Dimethyl fumarate Neuraxpharm Európska únia - slovenčina - EMA (European Medicines Agency)

dimethyl fumarate neuraxpharm

laboratorios lesvi s.l. - dimetylfumarát - roztrúsená skleróza, recidivujúce-odosielajúcej - imunosupresíva - dimethyl fumarate neuraxpharma is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.

Dimethyl fumarate Teva Európska únia - slovenčina - EMA (European Medicines Agency)

dimethyl fumarate teva

teva gmbh - dimetylfumarát - multiple sclerosis, relapsing-remitting; multiple sclerosis - imunosupresíva - dimethyl fumarate teva is indicated for the treatment of adult and paediatric patients aged 13 years and older with relapsing remitting multiple sclerosis (rrms).

Dimethyl fumarate Accord Európska únia - slovenčina - EMA (European Medicines Agency)

dimethyl fumarate accord

accord healthcare s.l.u. - dimetylfumarát - multiple sclerosis, relapsing-remitting; multiple sclerosis - imunosupresíva - dimethyl fumarate accord is indicated for the treatment of adult and paediatric patients aged 13 years and older with relapsing remitting multiple sclerosis (rrms).

Dimethyl fumarate Glenmark 240 mg Slovensko - slovenčina - ŠÚKL (Štátny ústav pre kontrolu liečiv)

dimethyl fumarate glenmark 240 mg

glenmark pharmaceuticals s.r.o., Česká republika - dimetyl-fumarát - 59 - immunopraeparata

Dimethyl fumarate Glenmark 120 mg Slovensko - slovenčina - ŠÚKL (Štátny ústav pre kontrolu liečiv)

dimethyl fumarate glenmark 120 mg

glenmark pharmaceuticals s.r.o., Česká republika - dimetyl-fumarát - 59 - immunopraeparata

Vumerity Európska únia - slovenčina - EMA (European Medicines Agency)

vumerity

biogen netherlands b.v. - diroximel fumarate (biib098) - roztrúsená skleróza, recidivujúce-odosielajúcej - imunosupresíva - vumerity is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis (see section 5. 1 for important information on the populations for which efficacy has been established).